Telcon RF Pharmaceutical (200230.KQ) Q4 2023 Earnings

20MarExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
14
15
15
15

Details

Expected EPS
N/A
Actual EPS
14
Surprise EPS
14
Surprise Percent
+∞%

Description

Telcon RF Pharmaceutical (200230.KQ) has reported earnings of 14 per share for Q4 2023.

0 Comments

Share your thoughts